General Information of DTT (ID: TTON5IT)

DTT Name Focal adhesion kinase 1 (FAK) DTT Info
UniProt ID
FAK1_HUMAN
Gene Name PTK2

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Investigative Drug(s)
Patented Agent(s)
Clinical Trial Drug(s)
7 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
VS-6063 DMGBLI3 Mesothelioma 2C51.2 Phase 2 [1]
BI-853520 DMNOSYW Solid tumour/cancer 2A00-2F9Z Phase 1 [2]
CEP-37440 DMV632P Solid tumour/cancer 2A00-2F9Z Phase 1 [2]
GSK-2256098 DMR24MI Pulmonary arterial hypertension BB01.0 Phase 1 [3]
IN10018 DMPXOVA Metastatic melanoma 2E2Z Phase 1 [4]
PF-562271 DMSLE03 Solid tumour/cancer 2A00-2F9Z Phase 1 [5]
VS-4718 DMN9JCD Solid tumour/cancer 2A00-2F9Z Phase 1 [6]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Clinical Trial Drug(s)
1 Patented Agent(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
1,2,4-triazolo[1,5a]pyridine derivative 1 DMIUPSA N. A. N. A. Patented [7]
------------------------------------------------------------------------------------
3 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
BMS-536924 DMXJB4N Discovery agent N.A. Investigative [8]
PF-228 DM32FKD Discovery agent N.A. Investigative [9]
PMID23414845C30 DMNVQ29 Discovery agent N.A. Investigative [10]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Role of focal adhesion kinase in regulating YB-1-mediated paclitaxel resistance in ovarian cancer. J Natl Cancer Inst. 2013 Oct 2;105(19):1485-95.
2 Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.
3 A small molecule FAK kinase inhibitor, GSK2256098, inhibits growth and survival of pancreatic ductal adenocarcinoma cells. Cell Cycle. 2014;13(19):3143-9.
4 Clinical pipeline report, company report or official report of InxMed.
5 Inhibition of focal adhesion kinase by PF-562,271 inhibits the growth and metastasis of pancreatic cancer concomitant with altering the tumor microenvironment. Mol Cancer Ther. 2011 Nov;10(11):2135-45.
6 FAK Inhibition disrupts a beta5 integrin signaling axis controlling anchorage-independent ovarian carcinoma growth. Mol Cancer Ther. 2014 Aug;13(8):2050-61.
7 Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 1.Expert Opin Ther Pat. 2017 Feb;27(2):127-143.
8 Discovery of a (1H-benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) inhibitor of insulin-like growth factor I receptor kinase with in vivo antitum... J Med Chem. 2005 Sep 8;48(18):5639-43.
9 Cellular characterization of a novel focal adhesion kinase inhibitor. J Biol Chem. 2007 May 18;282(20):14845-52.
10 Structure-based discovery of cellular-active allosteric inhibitors of FAK. Bioorg Med Chem Lett. 2013 Mar 15;23(6):1779-85.